• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Order
Home >> Antibodies >> PCSK9 Antibody

PCSK9 Antibody (F52952)

NSJ bio Image Pdf Image
  Catalog No Formulation Size Price (USD)  
Image F52952-0.4ML In 1X PBS, pH 7.4, with 0.09% sodium azide 0.4 ml 399
Image
F52952-0.08ML In 1X PBS, pH 7.4, with 0.09% sodium azide 0.08 ml 185
Bulk quote request
Western blot analysis of lysate from SK-N-MC cell line using PCSK9 antibody at 1:1000. Predicted size: Pro/mature ~74/64 kDa
Western blot analysis of lysate from SK-N-MC cell line using PCSK9 antibody at 1:1000. Predicted size: Pro/mature ~74/64 kDa
Availability 1-3 business days
Species Reactivity Human
Format Antigen affinity purified
Clonality Polyclonal (rabbit origin)
Isotype Rabbit Ig
Purity Antigen affinity
UniProt Q8NBP7
Applications Western blot : 1:1000
Limitations This PCSK9 antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

  • Applications : WB, IHC-P
    Reactivity : Human
  • Applications : FACS, IHC, WB, ELISA
    Reactivity : Human
  • Applications : IHC, FACS, WB, ELISA
    Reactivity : Human
  • Applications : WB, IHC-P, ELISA (peptide)
    Reactivity : Human
  • Applications : WB (transfected), ELISA (peptide)
    Reactivity : Human
  • Applications : WB (transfected), ELISA (peptide)
    Reactivity : Human
    Pred. Reactivity : Mouse, Rat
  • Applications : WB, IHC-P, Direct ELISA
    Reactivity : Human
  • Applications : WB, Direct ELISA
    Reactivity : Mouse, Rat

Description

Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation. Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway. Inhibits epithelial Na(+) channel (ENaC)-mediated Na(+) absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways.

Application Notes

Titration of the PCSK9 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Immunogen

This PCSK9 antibody was produced from a rabbit immunized with a KLH conjugated synthetic peptide between 654-688 amino acids from the C-terminal region of human PCSK9.

Storage

Aliquot the PCSK9 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Related Products

   1.   View all PCSK9 antibodies

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.